Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 157 | 1 | 138 | −18 |
| Shares | 86.1M | 2.63M | 83.1M | −423.9K (−0.5%) |
| Value | $477.2M | $14.6M | $229.4M | −$233.3M (−50.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (24)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (42)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 2,633,918 | $14.6M |